Literature DB >> 34415184

Immune cell β2-adrenergic receptors contribute to the development of heart failure.

Miles A Tanner1, Charles A Maitz2, Laurel A Grisanti1.   

Abstract

β-Adrenergic receptors (βARs) regulate normal and pathophysiological heart function through their impact on contractility. βARs are also regulators of immune function where they play a unique role depending on the disease condition and immune cell type. Emerging evidence suggests an important role for the β2AR subtype in regulating remodeling in the pathological heart; however, the importance of these responses has never been examined. In heart failure, catecholamines are elevated, leading to chronic βAR activation and contributing to the detrimental effects in the heart. We hypothesized that immune cell β2AR plays a critical role in the development of heart failure in response to chronic catecholamine elevations through their regulation of immune cell infiltration. To test this, chimeric mice were generated by performing bone marrow transplant (BMT) experiments using wild-type (WT) or β2AR knockout (KO) donors. WT and β2ARKO BMT mice were chronically administered the βAR agonist isoproterenol. Immune cell recruitment to the heart was examined by histology and flow cytometry. Numerous changes in immune cell recruitment were observed with isoproterenol administration in WT BMT mice including proinflammatory myeloid populations and lymphocytes with macrophages made up the majority of immune cells in the heart and which were absent in β2ARKO BMT animal. β2ARKO BMT mice had decreased cardiomyocyte death, hypertrophy, and interstitial fibrosis following isoproterenol treatment, culminating in improved function. These findings demonstrate an important role for immune cell β2AR expression in the heart's response to chronically elevated catecholamines.NEW & NOTEWORTHY Immune cell β2-adrenergic receptors (β2ARs) are important for proinflammatory macrophage infiltration to the heart in a chronic isoproterenol administration model of heart failure. Mice lacking immune cell β2AR have decreased immune cell infiltration to their heart, primarily proinflammatory macrophage populations. This decrease culminated to decreased cardiac injury with lessened cardiomyocyte death, decreased interstitial fibrosis and hypertrophy, and improved function demonstrating that β2AR regulation of immune responses plays an important role in the heart's response to persistent βAR stimulation.

Entities:  

Keywords:  cardiac; heart failure; inflammation; β2-adrenergic receptor

Mesh:

Substances:

Year:  2021        PMID: 34415184      PMCID: PMC8816326          DOI: 10.1152/ajpheart.00243.2021

Source DB:  PubMed          Journal:  Am J Physiol Heart Circ Physiol        ISSN: 0363-6135            Impact factor:   5.125


  77 in total

1.  Opposing effects of beta(1)- and beta(2)-adrenergic receptors on cardiac myocyte apoptosis : role of a pertussis toxin-sensitive G protein.

Authors:  C Communal; K Singh; D B Sawyer; W S Colucci
Journal:  Circulation       Date:  1999-11-30       Impact factor: 29.690

2.  Genetic Regulation of Fibroblast Activation and Proliferation in Cardiac Fibrosis.

Authors:  Shuin Park; Sara Ranjbarvaziri; Fides D Lay; Peng Zhao; Mark J Miller; Jasmeet S Dhaliwal; Adriana Huertas-Vazquez; Xiuju Wu; Rong Qiao; Justin M Soffer; Christoph Rau; Yibin Wang; Hanna K A Mikkola; Aldons J Lusis; Reza Ardehali
Journal:  Circulation       Date:  2018-09-18       Impact factor: 29.690

3.  Treatment of chronic heart failure with β-adrenergic receptor antagonists: a convergence of receptor pharmacology and clinical cardiology.

Authors:  Michael R Bristow
Journal:  Circ Res       Date:  2011-10-28       Impact factor: 17.367

4.  Clinical and hemodynamic correlates of sympathetic nerve activity in normal humans and patients with heart failure: evidence from direct microneurographic recordings.

Authors:  D W Ferguson; W J Berg; J S Sanders
Journal:  J Am Coll Cardiol       Date:  1990-11       Impact factor: 24.094

5.  Plasma norepinephrine as a guide to prognosis in patients with chronic congestive heart failure.

Authors:  J N Cohn; T B Levine; M T Olivari; V Garberg; D Lura; G S Francis; A B Simon; T Rector
Journal:  N Engl J Med       Date:  1984-09-27       Impact factor: 91.245

6.  Comparison of carvedilol and metoprolol on clinical outcomes in patients with chronic heart failure in the Carvedilol Or Metoprolol European Trial (COMET): randomised controlled trial.

Authors:  Philip A Poole-Wilson; Karl Swedberg; John G F Cleland; Andrea Di Lenarda; Peter Hanrath; Michel Komajda; Jacobus Lubsen; Beatrix Lutiger; Marco Metra; Willem J Remme; Christian Torp-Pedersen; Armin Scherhag; Allan Skene
Journal:  Lancet       Date:  2003-07-05       Impact factor: 79.321

7.  Altered expression of beta-adrenergic receptor kinase and beta 1-adrenergic receptors in the failing human heart.

Authors:  M Ungerer; M Böhm; J S Elce; E Erdmann; M J Lohse
Journal:  Circulation       Date:  1993-02       Impact factor: 29.690

Review 8.  Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.

Authors:  Stephane Heymans; Emilio Hirsch; Stefan D Anker; Pal Aukrust; Jean-Luc Balligand; Jan W Cohen-Tervaert; Helmut Drexler; Gerasimos Filippatos; Stephan B Felix; Lars Gullestad; Denise Hilfiker-Kleiner; Stefan Janssens; Roberto Latini; Gitte Neubauer; Walter J Paulus; Burkert Pieske; Piotr Ponikowski; Blanche Schroen; Heinz-Peter Schultheiss; Carsten Tschöpe; Marc Van Bilsen; Faiez Zannad; John McMurray; Ajay M Shah
Journal:  Eur J Heart Fail       Date:  2009-02       Impact factor: 15.534

Review 9.  Adrenergic regulation of innate immunity: a review.

Authors:  Angela Scanzano; Marco Cosentino
Journal:  Front Pharmacol       Date:  2015-08-13       Impact factor: 5.810

10.  The human heart contains distinct macrophage subsets with divergent origins and functions.

Authors:  Geetika Bajpai; Caralin Schneider; Nicole Wong; Andrea Bredemeyer; Maarten Hulsmans; Matthias Nahrendorf; Slava Epelman; Daniel Kreisel; Yongjian Liu; Akinobu Itoh; Thirupura S Shankar; Craig H Selzman; Stavros G Drakos; Kory J Lavine
Journal:  Nat Med       Date:  2018-06-11       Impact factor: 53.440

View more
  4 in total

1.  Modeling the physiological roles of the heart and kidney in heart failure with preserved ejection fraction during baroreflex activation therapy.

Authors:  John S Clemmer; W Andrew Pruett
Journal:  Am J Physiol Heart Circ Physiol       Date:  2022-08-19       Impact factor: 5.125

Review 2.  Role of adrenergic receptor signalling in neuroimmune communication.

Authors:  Sushanta Chhatar; Girdhari Lal
Journal:  Curr Res Immunol       Date:  2021-11-25

Review 3.  Neuroendocrine regulations in tissue-specific immunity: From mechanism to applications in tumor.

Authors:  Si-Qing Liu; Bei Li; Juan-Juan Li; Si Sun; Sheng-Rong Sun; Qi Wu
Journal:  Front Cell Dev Biol       Date:  2022-08-22

Review 4.  Cardiac Metabolism in Sepsis.

Authors:  Satoshi Kawaguchi; Motoi Okada
Journal:  Metabolites       Date:  2021-12-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.